Navigation Links
HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
Date:12/7/2010

ORLANDO, Fla., Dec. 7, 2010 /PRNewswire/ -- HemaQuest Pharmaceuticals, Inc. (HemaQuest), a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin-associated diseases, presented encouraging results at the ASH meeting in Orlando, Florida from its first two clinical trials evaluating its lead product candidate, HQK-1001, an orally administered Small Chain Fatty Acid Derivative (SCFAD) in patients with sickle cell disease and beta thalassemia.

In the sickle cell disease clinical trial, a total of 24 patients were randomized and treated once daily at one of three dose levels (10, 20 or 30 mg/kg) of HQK-1001 or placebo for two six-week cycles of therapy with a two-week treatment break between cycles. HQK-1001 was well-tolerated with no significant drug-related adverse events. In addition, increases in fetal hemoglobin levels, the key pharmacodynamic marker, were documented in patients treated at all HQK-1001 dose levels but not in the placebo-treated patients. There was also a trend of increasing rises of fetal hemoglobin levels with increased dose up to the maximum tested dose level of 30 mg/kg. Analysis of additional pharmacodynamic markers in selected patients demonstrated induction of fetal globin as manifested by increases in fetal hemoglobin containing red blood cells (F-cells) and fetal globin mRNA in the HQK-1001 treated patients.

In the beta thalassemia clinical trial, a total of 21 patients with beta thalassemia intermedia, including Hb E thalassemia, were randomized and treated once daily with HQK-1001 at one of four dose levels (10, 20, 30 or 40 mg/kg) or placebo for eight weeks. HQK-1001 was well-tolerated with no significant drug-related adverse events. Rises in fetal hemoglobin levels were observed in HQK-1001-treated patients, with the most consistent and largest effects observed at the 20 mg/kg dose level.

HemaQuest President and CEO John Longenecker, PhD, said, "These clinical trials provide
'/>"/>

SOURCE HemaQuest Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
2. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
3. Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company
4. Omthera Pharmaceuticals, Inc. to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.
8. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
9. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
10. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
11. Star Scientific Comments on Roskamp Institutes Plans to Conduct Human Alzheimers Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014  Diplomat, the nation,s largest independent specialty pharmacy, ... to the Board of Directors on September 15, 2014. ... serve as chair of the Audit Committee. ... financial, compliance and operating experience in the health care ... chief financial officer, chief operating officer and secretary of ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Alere Inc. ... rapid diagnostics, issued the following statement today in support ... Antibiotic-Resistant Bacteria. "As the global leader in ... for establishing a national strategy to address the serious ... to work with the Administration on initiatives to promote ...
(Date:9/19/2014)... September 19, 2014 Aufgrund ... den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch ... PDF, verfügbar unter pharmaserialisation.com , zeigt die ... jeweils in Kraft treten. Für international ... länger um das "ob", sondern darum, "wann" sie ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2
... 27 Data from a phase II study ... by increasing the frequency of bowel movements in ... analgesia. NKTR-118, an oral peripherally-acting opioid antagonist, ... for the treatment of opioid-induced constipation. ...
... Calif., Oct. 27 STAAR Surgical Company (Nasdaq: STAA ... ophthalmic products, today announced today that Deborah Andrews, Chief Financial ... at The Waldorf-Astoria Hotel on Wednesday, November 4th at 3:55 ... a live audio web cast of the presentation at ...
Cached Medicine Technology:Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 2Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 3Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego 4
(Date:9/21/2014)... -- Young women starting college understand the benefits of ... eat. But they aren,t confident they can follow through ... study. The study involved 268 female college ... Exercising and Eating Right program. The students answered food-related ... if they were very busy with school work, were ...
(Date:9/21/2014)... To accommodate the ever-growing customer base, ... more trendy items. Recently, the company has unveiled its ... new and elegant wedding gowns, Angeldress.co.uk wants to make ... in an easy way. Its high quality vintage wedding ... 12% off to 62% off. , Online shopping is ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Recently, BambooIndustry.com, ... a special offer for its bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ... the market; all of them are available at discounted ... , The company’s discounted bamboo panels are ... made of quality materials. Each of them is finely ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, ... GreenGeeks are the most recommended hosting suppliers for ... quality hosting products. , “Don’t waste your ... recommend two great hosting companies to you,” the ... iPage and GreenGeeks are the most recommended suppliers ...
(Date:9/20/2014)... 6 Minutes to Skinny , a ... Ballantyne that is showing men and women of all ages ... body fat using simple 6-minute exercises and easy-to-follow lifestyle tips ... investigative review. , “When it comes to losing body ... out for all people,” reports Michaels. “Metabolism plays a big ...
Breaking Medicine News(10 mins):Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... A disease called Onchocerciasis, river blindness or craw craw ... presents as a weakening// in affected individuals thus rendering ... turn adversely impacts the economy of this area. The ... is transmitted through the bite of the black fly, ...
... issued serious warnings against the use of products containing ... , These products are mainly sold to treat the ... highly corrosive and consuming them leads to stomach irritation ... Administration also said that intravenous injections of such products ...
... study published in the British Journal of Psychology showed that ... team of psychologist who wanted to test their theory linking ... hungry men preferred heavier women. ,Dr Viren ... Martin Tovee from Newcastle University conducted the study among 60 ...
... the Indian Space Research Organisation (ISRO) has said that there ... make it easier for detecting sensitive diseases. Mr Nair was ... CT scanner at Narayana Hrudayalaya at Bangalore. ,"Almost all ... context that early detection of heart disease gains importance," he ...
... According to the third phase of clinical trail conducted by ... that a weekly dose of erythropoietin //(EPO) is a very ... during chemotherapy. ,EPO is a natural hormone that ... red blood cell (RBC) transfusions in these children. This ...
... vehicle for delivering radioactive iodine dose to cure deadly ... ,Synthetic scorpion venom is used as carriers for ... is successfully complete and was conducted by under Adam ... Maxine Dunitz Neurosurgical Institute. About 18 patients participated in ...
Cached Medicine News:Health News:Onchocerciasis: Presentation And Treatment 2Health News:EPO Effective For Cancer Patients Suffering From Anemia 2Health News:New Carrier Developed To Deliver Drugs to Gliomas 2Health News:New Carrier Developed To Deliver Drugs to Gliomas 3
Inquire...
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
... is a blower-based, bi-level positive pressure ventilator ... weighing 30 kg or more. The KnightStar ... insufficiency and/or obstructive sleep apnea in the ... KnightStar 330 Ventilator includes a 3-30 cm ...
... The BiPAP Pro with Bi-Flex bi-level system, ... that the BiPAP Pro takes to change ... Digital Auto-Trak Sensitivity™ which automatically triggers the ... pressures based on the patients breathing rhythm. ...
Medicine Products: